— Disease indication: metabolic disorders including insulin resistance and diabetic nephropathy
Drug format: chemically modified synthetic microRNA (miRNA)
Drug class: first-in-class for metabolic disease
Research stage and Preliminary data:
Target: miR-29 mimics can increase the gene expressio…
— Species: Human
Target: SARS-CoV-2 nucleocapsid protein
Applications:
Description: Two recombinant fully human monoclonal antibodies that recognize SARS-CoV-2 spike protein (data below).
Related Web Links: Ellebedy Profile; Ellebedy Lab
— Species: Mouse
Target: SARS-CoV-2 spike protein
Applications:
Description: Four murine monoclonal antibodies that recognize SARS-CoV-2 spike protein. Data below includes avaiable antibodies (mCoV.1.1C02; mCoV.1.2C08; mCoV.1.2D09; mCoV.1.2F05).
Related Web Links: Ellebedy Profile; Ellebedy Lab
…
— Species: Human
Target: SARS-CoV-2 spike protein
Applications:
Description: Ten recombinant fully human monoclonal antibodies that recognize SARS-CoV-2 spike protein (data below).
Related Web Links: Ellebedy Profile; Ellebedy Lab
Available Antibodies
mAb name
Ag
30.0000
10.0…
— Species: Mouse
Target: SARS-CoV-2 spike protein
Applications:
Data: See table below for library of antibodies, inventor can recommend specific clones based on intended application.
Related Web Links: Diamond Profile
Available Antibodies
Ab:
Well #
Final Boost
flow cytometer…
| Name | # Summaries | Author |
|---|---|---|
| 15 | ||
| 13 | ||
| 15 | ||
| 26 | ||
| 14 | ||
| 14 |
Creating...
